Admission to Premium Listing & Trading on the LSE

RNS Number : 7773H
CVC Credit Partners European OpsLtd
25 June 2013
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, SOUTH AFRICA, CANADA, IRELAND OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

25 June 2013

CVC Credit Partners European Opportunities Limited
Admission to the premium listing segment of the Official List and to trading on the London Stock Exchange

Further to its announcement on 20 June 2013, CVC Credit Partners European Opportunities Limited (the "Company") is pleased to announce that its entire ordinary share capital of 174,729,500 million Euro denominated shares and 150,849,080 million Sterling denominated shares have today been admitted to the premium listing segment of the Official List of the UK Financial Conduct Authority and to trading on the London Stock Exchange plc's main market for listed securities under the following tickers.

 


Ticker

Euro denominated share

CCPE

Sterling denominated share

CCPG

 

Goldman Sachs International is acting as Sponsor, Global Co-ordinator and Bookrunner in relation to the Placing and Dexion Capital plc is acting as Lead Placing Agent in relation to the Placing.

 

ENQUIRIES

Brunswick Group

Rowan Brown

Edward Moore

+44 20 7404 5959



Goldman Sachs International

Richard Cormack

Shomick Bhattacharya

John Brennan

+44 20 7774 1000



Dexion Capital plc

Ravi Anand

Katie Standley

+44 20 7832 0900



 

IMPORTANT NOTICES

Neither this announcement nor the information contained herein is for release, publication or distribution, directly or indirectly, in or into the United States, South Africa, Canada, Ireland or Japan or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction. The securities referred to herein have not been and will not be registered under the relevant securities laws of any such excluded territory.

This announcement does not contain, constitute or form part of an offer for sale of, or the solicitation of an offer to purchase, securities in the United States or to U.S. Persons (as defined in Regulation S of the Securities Act). The securities referred to herein have not been, and will not, be registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States or to, or for the account or benefit of, any U.S. Person. There will be no offer of the Company's securities in the United States.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase or subscribe for any ordinary shares or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract. The initial public offering of ordinary shares in the Company (the "Placing") and the distribution of this announcement and other information in connection with the listing and the Placing in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about, and observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

Subject to certain exceptions, the securities referred to herein may not be offered or sold in South Africa, Canada, Ireland or Japan or to, or for the account or benefit of, any national, resident or citizen of Canada, Japan, Ireland or South Africa. There will be no public offering of securities in the United States, Canada, South Africa, Japan or Ireland.

This announcement is directed only at persons in member states of the European Economic Area (the "EEA") who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC) (as amended, including by Directive 2010/73/EU, to the extent such amendments have been implemented in the relevant Member State and including any relevant implementing measure in the relevant Member State) ("Qualified Investors"). In addition, in the United Kingdom, this announcement is directed only at Qualified Investors who are: (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended from time to time (the "Order"); or (ii) high net entities and other persons to whom it may lawfully be communicated within Article 49(2) of the Order (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this announcement relates will only be available to and will only be engaged in with: (a) in the United Kingdom, persons who are Relevant Persons; and (b) in any other member state of the EEA, persons who are Qualified Investors. Any person in the United Kingdom who is not a Relevant Person or any person in any other member state of the EEA who is not a Qualified Investor should not act or rely on this document or any of its contents.

Goldman Sachs International ("GSI"), which is authorised by the Prudential Regulatory Authority and regulated in the United Kingdom by the Prudential Regulatory Authority and the Financial Conduct Authority, is acting exclusively for the Company and no-one else in connection with the Placing. GSI will not regard any other person as its client in relation to the Placing and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, nor for providing advice in relation to the Placing, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

Dexion Capital plc ("Dexion"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for the Company and no-one else in connection with the Placing. Dexion will not regard any other person as its client in relation to the Placing and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, nor for providing advice in relation to the Placing, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

None of GSI, Dexion nor any of their respective directors, officers, employees, advisers, affiliates or agents accepts any responsibility or liability whatsoever for, or makes any representation,  warranty or undertaking, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company or its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith. Each of GSI and Dexion and any of their respective directors, officers, employees, advisers, affiliates or agents expressly disclaim any  obligation or undertaking to update, review or revise this announcement whether as a result of new information, future developments or otherwise.

The Company is regulated by the Jersey Financial Services Commission and has been established in Jersey as a listed fund under a fast-track authorisation process. It is suitable therefore only for professional or experienced investors, or those who have taken appropriate professional advice.

Regulatory requirements which may be deemed necessary for the protection of retail or inexperienced investors, do not apply to listed funds. By investing in the Company you will be deemed to be acknowledging that you are a professional or experienced investor, or have taken appropriate professional advice, and accept the reduced requirements accordingly.

You are wholly responsible for ensuring that all aspects of the Company are acceptable to you. Investment in listed funds may involve special risks that could lead to a loss of all or a substantial portion of such investment. Unless you fully understand and accept the nature of the Company and the potential risks inherent in it you should not invest in the Company.

Further information in relation to the regulatory treatment of listed funds domiciled in Jersey may be found on the website of the Jersey Financial Services Commission at www.jerseyfsc.org

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUAUQUPWUMA
UK 100